Pfizer seeks US approval of booster dose of its COVID-19 vaccine

Pfizer is seeking US approval of a booster dose of its two-shot COVID-19 vaccine, The Associated Press reported on Wednesday.

The drugmaker said that it has started the application process for a third dose of its vaccine for everyone ages 16 and older. The company said it will complete the application with the Food and Drug Administration by the end of this week.